Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods
Выявление мощных ингибиторов транспортера 1 крупных нейтральных аминокислот (LAT1) методами, основанными на структуре
2018-12-21
SCID: 54.1/h4vnr8gb
Discuss with AI
LAT1 inhibitorsdynamic pharmacophoresmolecular dockingstructure-based drug discoveryvirtual screening
Figures from the paper
Abstract (AI)
The large neutral amino acid transporter 1 (LAT1) is a promising anticancer target that is required for the cellular uptake of essential amino acids that serve as building blocks for cancer growth and proliferation. Here, we report a structure-based approach to identify chemically diverse and potent inhibitors of LAT1. First, a homology model of LAT1 that is based on the atomic structures of the prokaryotic homologs was constructed. Molecular docking of nitrogen mustards (NMs) with a wide range of affinity allowed for deriving a common binding mode that could explain the structure−activity relationship pattern in NMs. Subsequently, validated binding hypotheses were subjected to molecular dynamics simulation, which allowed for extracting a set of dynamic pharmacophores. Finally, a library of ~1.1 million molecules was virtually screened against these pharmacophores, followed by docking. Biological testing of the 30 top-ranked hits revealed 13 actives, with the best compound showing an IC50 value in the sub-μM range.
Key Findings
1
A homology model of LAT1 was constructed using atomic structures of prokaryotic LAT1 homologs.
2
Docking nitrogen mustards with diverse affinities identified a common LAT1 binding mode explaining their structure–activity relationships.
3
Molecular dynamics simulations of validated binding hypotheses generated dynamic pharmacophores for inhibitor discovery.
4
The most potent identified LAT1 inhibitor exhibited an IC50 value in the sub-micromolar range.
5
Virtual screening of approximately 1.1 million molecules followed by docking produced 13 active compounds among 30 tested top-ranked hits.
Research Object
large neutral amino acid transporter 1 (LAT1)
Research Subject
the binding interactions, structure–activity relationships, and inhibitory potency of chemically diverse LAT1 inhibitors
Publication Details
Publication Date
2018-12-21
Journal
Publisher
ISSN
Cited by
59
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Cited by4
Amino acids in cancer2020
The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer2019
Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter2021
LAT1-specific PET radiotracers: Development and clinical experiences of a new class of cancer-specific radiopharmaceuticals2025